logo
AAT Bioquest

Amplite® Fluorimetric Glucose-6-Phosphate Assay Kit

G6P dose response was measured with Amplite® Fluorimetric G6P Assay Kit in a 96-well solid black plate using a Gemini (Molecular Devices) microplate reader.
G6P dose response was measured with Amplite® Fluorimetric G6P Assay Kit in a 96-well solid black plate using a Gemini (Molecular Devices) microplate reader.
G6P dose response was measured with Amplite® Fluorimetric G6P Assay Kit in a 96-well solid black plate using a Gemini (Molecular Devices) microplate reader.
Ordering information
Price
Catalog Number
Unit Size
Quantity
Add to cart
Additional ordering information
Telephone1-800-990-8053
Fax1-800-609-2943
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
ShippingStandard overnight for United States, inquire for international
Request quotation
Storage, safety and handling
H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
UNSPSC12352200

OverviewpdfSDSpdfProtocol


Glucose-6-phosphate (G6P) is a key intermediate for glucose transport into cells. G6P may also be converted to glycogen or starch for storage in the liver and muscles. G6P is utilized by glucose-6-phosphate dehydrogenase (G6PD) to generate the reducing equivalents in the form of NADPH. This is particularly important in red blood cells where G6PD deficiency leads to hemolytic anemia. AAT Bioquest's Amplite® Fluorimetric Glucose-6-Phosphate Assay Kit provides a simple, sensitive and rapid fluorescence-based method for detecting G6P in biological samples such as serum, plasma, urine, as well as in cell culture samples. In the coupled enzyme assay, the G6P concentration is proportionally related to NADPH that is specifically monitored by a fluorogenic NADPH sensor. The fluorescence signal can be read by a fluorescence microplate reader. With the Amplite® G6P Assay Kit, we were able to detect as little as 0.3 µM G6P in a 100 µL reaction volume.

Platform


Absorbance microplate reader

Absorbance575/605 nm
Recommended plateClear bottom

Fluorescence microplate reader

Excitation540 nm
Emission590 nm
Cutoff570 nm
Recommended plateSolid black

Components


Example protocol


AT A GLANCE

Protocol summary

  1. Prepare G6P working solution (50 µL)
  2. Add G6P standards or test samples (50 µL)
  3. Incubate at room temperature for 30 minutes - 2 hours
  4. Monitor fluorescence increase at Ex/Em = 540/590 nm (Cutoff = 570 nm)

Important notes
Thaw kit components at room temperature before starting the experiment.

PREPARATION OF STOCK SOLUTION

Unless otherwise noted, all unused stock solutions should be divided into single-use aliquots and stored at -20 °C after preparation. Avoid repeated freeze-thaw cycles.

1. NADP stock solution (100X):
Add 100 µL of H2O into the vial of NADP (Component C) to make 100X NADP stock solution.

2. G6P standard solution (100 mM):
Add 100 µL of H2O or 1x PBS buffer into the vial of G6P Standard (Component D) to make 100 mM G6P standard solution.

PREPARATION OF STANDARD SOLUTION

G6P standard

For convenience, use the Serial Dilution Planner: https://www.aatbio.com/tools/serial-dilution/13804

Add 10 µL of 100 mM G6P standard solution into 990 µL 1x PBS buffer to generate 1 mM G6P standard solution. Then, add 100 µL of 1 mM G6P standard solution into 900 µL 1 x PBS buffer to make 100 µM G6P standard solution (G6P7). Take 100 µM G6P standard solution (G6P7) and perform 1:3 serial dilutions to get serially diluted G6P standards (G6P6 - G6P1) with 1x PBS buffer. Note: Diluted G6P standard solution is unstable, and should be used within 4 hours.

PREPARATION OF WORKING SOLUTION

1. Add 5 mL of Assay Buffer (Component B) into one bottle of Enzyme Probe (Component A), and mix well.

2. Add 50 µL of 100X NADP stock solution into the bottle of Component A+B, and mix well to make G6P working solution. Note: This G6P working solution is enough for one 96-well plate.

SAMPLE EXPERIMENTAL PROTOCOL

Table 1. Layout of G6P standards and test samples in a solid black 96-well microplate. G6P=G6P Standards (G6P1 - G6P7, 0.14 to 100 µM), BL=Blank Control, TS=Test Samples.

BLBLTSTS
G6P1G6P1......
G6P2G6P2......
G6P3G6P3  
G6P4G6P4  
G6P5G6P5  
G6P6G6P6  
G6P7G6P7  

Table 2. Reagent composition for each well.

WellVolumeReagent
G6P1 - G6P750 µLSerial Dilution (0.14 to 100 µM)
BL50 µLDilution Buffer
TS50 µLtest sample
  1. Prepare G6P standards (G6P), blank controls (BL), and test samples (TS) according to the layout provided in Tables 1 and 2. For a 384-well plate, use 25 µL of reagent per well instead of 50 µL.

  2. Add 50 µL of G6P working solution to each well of G6P standard, blank control, and test samples to make the total G6P assay volume of 100 µL/well. For a 384-well plate, add 25 µL of G6P working solution into each well instead, for a total volume of 50 µL/well.

  3. Incubate the reaction at room temperature for 30 minutes to 2 hours, protected from light.

  4. Monitor the fluorescence increase with a fluorescence plate reader at Excitation = 530 - 570 nm, Emission = 590 - 600 nm (optimal Ex/Em = 540/590 nm, Cutoff =  570nm). Note: The contents of the plate can also be transferred to a white clear bottom plate and read by absorbance microplate reader at the ratio of A575nm/A605nm. The absorption detection has lower sensitivity compared to fluorescence reading. 

Images


References


View all 84 references: Citation Explorer
The microsomal enzyme 17beta-hydroxysteroid dehydrogenase 3 faces the cytoplasm and uses NADPH generated by glucose-6-phosphate dehydrogenase
Authors: Legeza B, Balazs Z, Nashev LG, Odermatt A.
Journal: Endocrinology (2013): 205
Molecular characterization of glucose-6-phosphate dehydrogenase deficient variants in Baghdad city - Iraq
Authors: Al-Musawi BM, Al-Allawi N, Abdul-Majeed BA, Eissa AA, Jubrael JM, Hamamy H.
Journal: BMC Blood Disord (2012): 4
High prevalence of hemoglobin disorders and glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Republic of Guinea (West Africa)
Authors: Millimono TS, Loua KM, Rath SL, Relvas L, Bento C, Diakite M, Jarvis M, Daries N, Ribeiro LM, Manco L, Kaeda JS.
Journal: Hemoglobin (2012): 25
Effects of laparoscopic Roux-en-Y gastric bypass on glucose-6 phosphate dehydrogenase activity in obese type 2 diabetics
Authors: Schneider AM, Rawat D, Weinstein LS, Gupte SA, Richards WO.
Journal: Surg Endosc (2012): 823
A novel cytofluorometric assay for the detection and quantification of glucose-6-phosphate dehydrogenase deficiency
Authors: Shah SS, Diakite SA, Traore K, Diakite M, Kwiatkowski DP, Rockett KA, Wellems TE, Fairhurst RM.
Journal: Sci Rep (2012): 299
Effects of glucose-6-phosphate dehydrogenase deficiency on the metabolic and cardiac responses to obesogenic or high-fructose diets
Authors: Hecker PA, Mapanga RF, Kimar CP, Ribeiro RF, Jr., Brown BH, O'Connell KA, Cox JW, Shekar KC, Asemu G, Essop MF, Stanley WC.
Journal: Am J Physiol Endocrinol Metab (2012): E959
Glucose 6 phosphate dehydrogenase deficiency: a case series
Authors: E, undefined and i Eberle S, Garcia Rosolen N, Urtasun C, Sciuccati G, Diaz L, Savietto V, C and as A, Avalos Gomez V, Cervio C, Bonduel M, Feliu Torres A.
Journal: Arch Argent Pediatr (2011): 354
Glutathione-dependent enzymes and glucose-6-phosphate dehydrogenase of blood in patients with lymphosarcoma (non-Hodgkin's disease)
Authors: Gavriliuk LA, Korchmaru IF, Robu MV, Lysyi LT.
Journal: Biomed Khim (2011): 225
Glucose-6-phosphate dehydrogenase status and severity of malarial anaemia in Nigerian children
Authors: Orimadegun AE, Sodeinde O.
Journal: J Infect Dev Ctries (2011): 792
Implementation and analysis of a pilot in-hospital newborn screening program for glucose-6-phosphate dehydrogenase deficiency in the United States
Authors: Nock ML, Johnson EM, Krugman RR, Di Fiore JM, Fitzgerald S, S and haus LM, Walsh MC.
Journal: J Perinatol (2011): 112